Clinical investigations have confirmed elevated expression of EGFR as well as EGFR gene amplification in non-keratinizing NPC tumors, a correlation that has been linked to unfavorable treatment outcomes [21]. The gene discussed is EGFR; the disease is nasopharyngeal carcinoma.